14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.13 $4.97 Wednesday, 1st May 2024 ALDX stock ended at $4.20. This is 6.60% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 8.46% from a day low at $3.96 to a day high of $4.30.
90 days $2.71 $4.97
52 weeks $1.42 $11.97

Historical Aldeyra Therapeutics prices

Date Open High Low Close Volume
Feb 22, 2022 $3.76 $3.91 $3.76 $3.79 450 300
Feb 18, 2022 $3.85 $3.95 $3.76 $3.85 517 900
Feb 17, 2022 $4.04 $4.09 $3.85 $3.89 482 300
Feb 16, 2022 $4.20 $4.20 $3.97 $4.09 639 100
Feb 15, 2022 $3.80 $4.26 $3.80 $4.23 1 034 600
Feb 14, 2022 $3.90 $3.90 $3.71 $3.75 468 800
Feb 11, 2022 $3.99 $4.04 $3.83 $3.85 561 600
Feb 10, 2022 $3.93 $4.29 $3.91 $3.98 1 096 800
Feb 09, 2022 $3.76 $4.13 $3.76 $4.06 1 526 400
Feb 08, 2022 $3.67 $3.77 $3.50 $3.76 2 202 500
Feb 07, 2022 $3.53 $3.76 $3.53 $3.66 723 200
Feb 04, 2022 $3.59 $3.61 $3.38 $3.54 718 900
Feb 03, 2022 $3.53 $3.62 $3.41 $3.44 619 900
Feb 02, 2022 $3.73 $3.73 $3.45 $3.52 1 180 300
Feb 01, 2022 $3.64 $3.88 $3.63 $3.72 956 600
Jan 31, 2022 $3.40 $3.67 $3.31 $3.67 706 600
Jan 28, 2022 $3.27 $3.43 $3.17 $3.43 758 300
Jan 27, 2022 $3.47 $3.54 $3.26 $3.26 1 011 500
Jan 26, 2022 $3.55 $3.72 $3.38 $3.42 1 097 700
Jan 25, 2022 $3.44 $3.66 $3.34 $3.51 1 053 000
Jan 24, 2022 $3.18 $3.50 $3.00 $3.46 1 723 500
Jan 21, 2022 $3.42 $3.52 $3.24 $3.25 914 200
Jan 20, 2022 $3.52 $3.72 $3.43 $3.47 811 700
Jan 19, 2022 $3.52 $3.70 $3.52 $3.54 944 600
Jan 18, 2022 $3.75 $3.76 $3.47 $3.49 1 238 300
Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT